{"id":"W2077422669","doi":"10.1016/j.ygyno.2010.05.005","title":"A phase II study of erlotinib (OSI-774) given in combination with carboplatin in patients with recurrent epithelial ovarian cancer (NCIC CTG IND.149)","year":2010,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":false,"ca_institutions":"Ontario Institute for Cancer Research; Queen Elizabeth II Health Sciences Centre; BC Cancer Agency; Princess Margaret Cancer Centre; University Health Network; Juravinski Cancer Centre","funders":"","keywords":"Carboplatin; Erlotinib; Medicine; Ovarian cancer; Internal medicine; Oncology; Progressive disease; Chemotherapy; Epidermal growth factor receptor; Cancer; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004006391,0.0002701377,0.000830949,0.0003274322,0.00007299329,0.000006120288,0.0001283396,0.0002436021,0.0003583643],"category_scores_gemma":[0.0001310237,0.0001871617,0.00003691909,0.0005034585,0.0001248012,0.00007293828,0.00007641983,0.0005638005,0.000003738873],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007465052,"about_ca_system_score_gemma":0.000672931,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001822634,"about_ca_topic_score_gemma":0.05083659,"domain_scores_codex":[0.9979702,0.000196558,0.0005628195,0.0005334085,0.0003060012,0.0004310451],"domain_scores_gemma":[0.9987141,0.0002476628,0.0003947543,0.0003244029,0.0001984019,0.0001206605],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004510107,0.06184781,0.8382408,0.00003188193,0.0001521835,0.0001809321,0.002841457,0.00004050001,0.0001005125,0.0001023723,0.00007549646,0.09187596],"study_design_scores_gemma":[0.08722427,0.09968347,0.8114789,0.00007591653,0.0001891139,0.000004103481,0.0004092976,0.00005130766,0.0001133036,0.00005796292,0.0005495017,0.0001629133],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.994105,0.00003199049,0.000002274104,0.001106562,0.0005274997,0.003370464,0.00004386226,0.00002484302,0.0007874924],"genre_scores_gemma":[0.9980149,0.00001609578,0.0004725676,0.0001655347,0.00005132592,0.001160472,0.00005792142,0.00002384634,0.00003729752],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09171305,"threshold_uncertainty_score":0.9664832,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01666574657581773,"score_gpt":0.3167443559168022,"score_spread":0.3000786093409845,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}